Janus Henderson Group PLC Esperion Therapeutics, Inc. Transaction History

Janus Henderson Group PLC

  • $188 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$1.46 - $7.3 $19,956 - $99,783
13,669 Added 84.91%
29,767 $47,000
Q4 2022

Feb 14, 2023
BUY
$5.09 - $8.5 $81,938 - $136,833
16,098 New
16,098 $100,000
Q1 2020

May 14, 2020
SELL
$27.44 - $73.84 $107,729 - $289,895
-3,926 Closed
0 $0
Q4 2019

Feb 18, 2020
BUY
$35.4 - $59.82 $138,980 - $234,853
3,926 New
3,926 $234,000

Others Institutions Holding ESPR

# of Institutions
213
Shares Held
128M
Call Options Held
1.78M
Put Options Held
1.27M
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $63.2M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email